STOCK TITAN
  1. Home
  2. Sec-filings
  3. NNVC
  4. [EFFECT] NANOVIRICIDES, INC. SEC Filing

[EFFECT] NANOVIRICIDES, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 19, 2025 4:30 P.M.
Form: S-3
CIK: 0001379006
Company Name: NANOVIRICIDES, INC.
File Number: 333-292142

Source: View Original Filing on SEC EDGAR

Stock NNVC logo
Nanoviricides

NYSE:NNVC

NNVC Rankings

#5876 Ranked by Market Cap
N/A Ranked by Dividends

NNVC Latest News

Dec 1, 2025
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles
Nov 17, 2025
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
Nov 14, 2025
NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2
Nov 12, 2025
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
Nov 11, 2025
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

NNVC Latest SEC Filings

Dec 16, 2025
[DEL AM] NANOVIRICIDES, INC. SEC Filing
Dec 15, 2025
[S-3] NANOVIRICIDES, INC. Shelf Registration Statement
Nov 26, 2025
[8-K] NANOVIRICIDES, INC. Reports Material Event
Nov 14, 2025
[8-K] NANOVIRICIDES, INC. Reports Material Event
Nov 14, 2025
[10-Q] NANOVIRICIDES, INC. Quarterly Earnings Report

NNVC Stock Data

26.96M
17.40M
3.53%
8.31%
1.27%
Biotechnology
Pharmaceutical Preparations
Link
United States
SHELTON